Compare Charles River Laboratories Intl. Inc (CRL) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Target Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $231.16 (market cap $11.14B), while Target Corporation trades at $138.3 (market cap $60.86B). The key difference: Target Corporation is far larger — about 5.5× Charles River Laboratories Intl. Inc's market cap, and Target Corporation pays a 3.46% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | TGT | |
|---|---|---|
Market Cap | $11.14B | $60.86B |
Sector | Health | Consumer Cyclical |
52-Week High | $233.60 | $141.19 |
52-Week Low | $145.57 | $83.68 |
Enterprise Value | $14.00B | $76.16B |
Dividend Yield | — | 3.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
Target (TGT) trades at $134.77, down 0.27% today, with a bullish technical signal from moving averages and a neutral oscillator stance. The company maintains stable revenue around $106.6 billion (2025) and has beaten earnings estimates for three consecutive quarters. Recent dividend payments of $1.14 and $1.16 per share highlight its shareholder returns, while analyst consensus leans toward a buy rating with a $137 price target.
TGT presents a balanced opportunity with solid fundamentals and moderate valuation, but faces risks from competitive retail pressures and margin compression. Upside is supported by consistent earnings beats and dividend reliability, though investors should monitor consumer spending trends and inventory management challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
